The Royal Pharmaceutical Society (RPS) said despite the "incredibly exciting age" we live in, the market is "not set up to incentivise the production of new types of medicines".
RPS chief scientist Professor Jayne Lawrence said: "The current crisis in antimicrobial resistance is in part due to the lack of new classes of antibiotics coming on the market.
"Antibiotics can cure infections in weeks, so the volume of sales of drugs is low. This doesn't allow the tens or even hundreds of millions required for research and development to be recouped.
"Unless we find a way to develop treatments that cure illnesses in months, rather than treat symptoms for years, we will not see the breakthroughs that both scientists and patients want."
More top news
European nations are collectively consuming more fish than its waters can provide, according to a new study.
PM announces funding will be made available for a memorial dedicated to the victims of last week’s terrorist attack in Tunisia
Mother of the gunman in the Tunisia beach terror attack said her son once refused to kill a mouse because he "couldn't kill anything".